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OBJECTIVE — Paternal and maternal type 2 diabetes, exclusive of gestational diabetes, may
inﬂuence risk factors in the offspring differently (through possible epigenetic effects of parental
diabetes) and are difﬁcult to identify without accurate dates of diagnosis. We aimed to examine
a metabolic phenotype in three different groups of offspring to see distinct paternal versus
maternal effects.
RESEARCHDESIGNANDMETHODS — Weexaminedbodycompositionandinsulin
action (M) in nondiabetic subjects and insulin secretion tested via acute insulin response (AIR)
in normal glucose-tolerant full-heritage Pima Indian adults categorized by disparate parental
diabetesstatus:1)offspringoffatherswithearly-onsetdiabetes(age35years)andnondiabetic
mothers (ODF; n  10), 2) offspring of mothers with early-onset diabetes (age 35 years), not
exposed to diabetes in utero with nondiabetic fathers (OMED; n  11), and 3) a control group
of offspring of parents without diabetes until 50 years of age (CON; n  15).
RESULTS — ODFs were leaner than CONs and OMEDs (percent of body fat [%BF]: least-
squaresmeansadjustedforageandsex[95%CI]:27.3[23.3–31.3]inODFsvs.35.4[32.2–38.5]
in CONs and 32.4 [28.8–36.1] in OMEDs, P  0.04). ODFs were more insulin sensitive (had a
higher M) than OMEDs or CONs, but not after adjustment for age, sex, and %BF. AIR adjusted
for M, age, sex, and %BF was lower in ODFs versus CONs and OMEDs (P  0.05).
CONCLUSIONS — Adult ODFs were leaner and had lower early insulin secretion, despite
being equally insulin sensitive after adjustment for body fat compared to the other groups,
indicating a paternal imprinted effect.
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P
revious studies of heredity estab-
lished parental history of type 2 di-
abetes as one of the dominant risk
factors for the development of type 2 di-
abetes (1,2). The offspring phenotype
may vary depending on which parent is
affected and whether the offspring was
exposed to diabetes in utero. Low birth
weight (LBW), thought to result from in
utero maternal undernutrition, is one
such phenotypic feature and has been
showntopredictthedevelopmentoftype
2 diabetes (3,4). However, in Pima Indi-
ans,LBWpredictsdiabetesonlywhenpa-
ternal (not maternal) diabetes is present
(3). In fact, offspring’s lower birth weight
predicted subsequent development of di-
abetes in the fathers. These data indicated
a possible paternally transmitted im-
printed effect. Gautier et al. (5) reported
that insulin secretion was positively asso-
ciated with age of diabetes onset in the
mother. However, this was in a mixed co-
hortinwhicheitherorbothparentscould
have had diabetes.
Recent studies in mice demonstrated
thatalthoughaLBWphenotype,ﬁrstgen-
erated using maternal undernutrition,
confers impaired glucose tolerance via
both subsequent parental lines, the LBW
phenotype is passed on via paternal in-
heritance only (6). As these mice reach
maturity, paternal offspring continue to
have lower body weight but similar de-
grees of impairment in glucose tolerance
and impaired insulin secretion.
We hypothesized that offspring of in-
dividuals with early-onset paternal diabe-
tes would have a different metabolic
phenotype than those with early-onset
maternal diabetes (exclusive of exposure
to diabetes in utero) and control subjects.
To disentangle the separate parental ef-
fects in offspring, we carefully selected
three groups of individuals: 1) offspring
of fathers with early onset of diabetes, 2)
offspring of mothers with early onset of
diabetes, and 3) offspring in which nei-
ther parent developed diabetes. We com-
pared body composition (percentage of
body fat [%BF]), insulin action (M), and
acute insulin response (AIR) among these
groups.
RESEARCH DESIGN AND
METHODS
Determination of parental
diabetes status
Parental diabetes status was determined
from a longitudinal study of health con-
ducted within the Gila River (Pima) In-
dian Community in which residents 5
years old have been invited for research
examinations consisting of the measure-
mentofheightandweightanda75-goral
glucose tolerance test (OGTT) approxi-
mately every 2 years. Diabetes was diag-
nosed according to World Health
Organization 1999 criteria (7) or by re-
view of the medical record if made in a
clinical setting.
We deﬁned three groups of offspring
according to parental diabetes status: 1)
offspring of diabetic fathers (ODF) con-
sistingofsubjectswhosefatherdeveloped
diabetes at 35 years of age, but whose
mother remained nondiabetic until 35
years of age; 2) offspring of mothers with
earlyonsetofdiabetes(OMED)consisting
of subjects whose mother developed dia-
betes at 35 years of age, but after the
date of birth of the subject documented
by a normal OGTT following delivery
(mean  SD time between subject’s date
of birth and mothers date of diagnosis,
8.9  4.2 years), and whose fathers re-
mained nondiabetic until 35 years of
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sisting of offspring whose parents were
known to be nondiabetic until 50 years
of age. The third group can be considered
a control group because of previous evi-
dence that offspring of parents who do
not develop diabetes until age 50 years
have a risk for developing diabetes com-
parable with that of offspring whose par-
ents never developed diabetes (8).
For additional characterization of the
parents, we determined the diabetic cu-
mulativeincidence(CI)scoreofeachpar-
ent in the sample (8). Brieﬂy, the diabetes
score was derived by ﬁrst calculating the
speciﬁc cumulative incidence of diabetes
as a function of age (CIa) in the Pima pop-
ulation. If diabetes was present, then the
scoreiscalculatedby1CIaattheageof
ﬁrst diagnosis of diabetes. If diabetes was
not present, then score is calculated as
0  CIa at the time of the last biennial
examination. The score thus contains in-
formation on whether an individual de-
veloped diabetes and the age of onset of
diabetes and is positive if diabetes was
ever present and greater if diabetes devel-
oped at an earlier age. Conversely, a neg-
ative score is calculated if the individual
wasnondiabeticatthelastbiennialexam-
ination and is most negative in those who
remain nondiabetic into old age.
Study subjects
Volunteers also participated in a study of
metabolic determinants for the develop-
mentoftype2diabetesandobesity.Atthe
time of their participation, all subjects
wereingoodhealthandwithoutevidence
of diabetes (by OGTT), as determined by
a comprehensive medical evaluation in-
cluding medical history, physical exami-
nation, and routine laboratory testing.
Subjectswereadmittedfor10–15daysto
the Clinical Research Unit of the National
Institute of Diabetes and Digestive and
Kidney Diseases in Phoenix, Arizona, and
were provided a standard weight-
maintaining energy needs diet containing
50% of calories as carbohydrate, 30% as
fat, and 20% as protein for at least 3 days
before metabolic testing. After at least 3
days,volunteersunderwenta75-gOGTT
after a 12-h overnight fast to exclude
diabetes. Volunteers were then assessed
forbodycompositionandinsulinaction
in vivo. Only subjects who were full-
heritage Pima Indian or related Tohono
O’odham were included in the analysis.
Dual-energy X-ray absorptiometry
Bodycompositionwasmeasuredbydual-
energy X-ray absorptiometry using a total
body scanner (DPX-L; Lunar, Madison,
WI). Percentage body fat (%BF), fat mass
(FM), and fat-free mass (FFM) were cal-
culated as previously described (9).
Measurement of insulin action
Insulin action was assessed at physiolog-
ical insulin concentrations during the hy-
perinsulinemic-euglycemic clamp
technique (10). Brieﬂy, after an overnight
fast, a primed (30 Ci) continuous (0.3
Ci/min) infusion of [3-
3H] glucose was
started to determine endogenous glucose
production (EGP). At least 2 h after start-
ing the isotope infusion, a primed contin-
uous intravenous insulin infusion was
administered for 100 min at a constant
rate of 40 mU/m
2/min. Blood samples for
measurement of [3-
3H] glucose speciﬁc
activity were collected at the end of the
basal period and every 10 min during the
ﬁnal 40 min of insulin infusion. Under
basal (i.e., fasting) conditions, EGP was
calculated as the [3-
3H] glucose infusion
rate divided by the steady-state plasma
3-[
3H] glucose speciﬁc activity. The rate
of total insulin-stimulated glucose dis-
posal was calculated for the last 40 min of
the insulin infusion and was corrected for
the rate of EGP calculated from the Steele
equation (11). Individual variation in
plasma glucose and insulin concentra-
tions during the clamp were taken into
account in the calculation of insulin ac-
tion (M-low) (12). All measurements de-
rived from the clamp were normalized to
estimated metabolic body size (EMBS),
which is directly derived from FFM but
takes into account the fact that the inter-
cept of the relationship between FFM and
resting metabolic rate is not zero (17.7
kginourlaboratory[i.e.,EMBSFFM
17.7 kg]) (12).
Insulin secretion
Insulin secretion was measured as the re-
sponse to a 25-g intravenous glucose tol-
erance test (IVGTT). The AIR was
calculated as the average increment in
plasma insulin concentration above basal
in samples obtained 3, 4, and 5 min after
the bolus injection of glucose (13).
Meal test
At 0730 h, subjects were fed a mixed-
meal breakfast (consisting of a bacon-
and-egg sandwich on toast accompanied
by orange juice) containing 10% of calo-
ries from protein, 45% from fat, and 45%
fromcarbohydratesandproviding20%
ofdailyenergyrequirementsforeachsub-
ject. The meal was consumed within 15
min, and subjects rested quietly in bed
throughout the study. Blood samples for
insulin and glucose were drawn before
and 30, 60, 90, 120, 150, and 180 min
after initiation of the meal test.
Analytic measurements
Plasma glucose concentrations were mea-
sured by the glucose oxidize method
(Beckman Instruments, Fullerton, CA).
Plasma insulin concentrations were mea-
sured by the Herbert modiﬁcation of the
method of Yalow and Berson (14), by an
automated auto-analyzer (ICN Radio-
chemicals, Costa Mesa, CA), or by an au-
tomated immunoassay (Access, Beckman
Instruments). Values from the ﬁnal two
assays were regressed to the original
assay.
All studies were approved by the In-
stitutional Review Board of the National
Institute of Diabetes and Digestive and
Kidney Disease. All volunteers gave writ-
ten, informed consent.
Statistical analysis
Statistical analyses were performed using
theproceduresoftheSASstatisticalpack-
age(version8.2;SASInstitute,Cary,NC).
AIRandM-lowwerelog10transformedto
normalize their distributions before para-
metric analyses. Unless otherwise speci-
ﬁed, all data are expressed as means 
SD. General, anthropometric, and meta-
bolic characteristics in Table 1 were eval-
uated using Student’s t test, ANOVA, or
	
2 analyses for continuous and categori-
cal variables, respectively. Since even
milddegreesofglucoseintolerancecanbe
associatedwithimpairmentsininsulinse-
cretion (15) only subjects with normal
glucose tolerance were included for fur-
ther analyses of AIR. The glucose and in-
sulin responses during the OGTT,
IVGTT,andmealtestbygroupwerecom-
paredbyANCOVAusingtheMIXEDpro-
cedure in SAS. The general linear models
were used to adjust %BF for age and sex;
M-low (mg   kg
1   estimated metabolic
body size (EMBS)   min
1) for age, sex,
and %BF, and AIR for age, sex, %BF, and
M-low (10). Adjusted least-squares
means (lsmeans) were used to compare
groups by parental diabetes status using
post hoc t test, with Tukey’s honestly sig-
niﬁcant difference adjustment for multi-
ple comparisons. For all groups, further
analyseswereconductedandadjustedfor
thesamecovariatesusinggeneralestimat-
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RESULTS— General, anthropomet-
ric, and metabolic characteristics of the
study population are shown in Table 1.
We found 10 ODF; 8 of 10 fathers from
the ODF group had diabetes preconcep-
tion, and 2 fathers had diagnoses of dia-
betes 3 and 4 years after the offspring
birth.Onsetageofdiabetesforfatherswas
lower in the ODF group than for mothers
in the OMED group (26.6  4.2 vs.
30.4  3.0 years, P  0.02). This slight
difference in age was due to exclusion of
mothers in the OMED group who did not
have a nondiabetic OGTT following
childbirth.Consistentwiththisagediffer-
ence, fathers’ CI score in the ODF group
was higher than mothers’ CI score in the
OMED group (P  0.04, Table 1). There
was no signiﬁcant difference between
mothers CI score in the ODF group and
fathers CI score in the OMED group, in-
dicating no difference in relative age of
onset of diabetes in the opposite parent.
The CI score was comparable between
mothers and fathers in the CON group
(Table 1). The birth weight and height
was not different among the three groups
(Table 1).
ODFs had lower mean %BF than
CONs or OMEDs (Table 1). After adjust-
ment for age and sex, %BF remained
lower in the ODF group than in the CON
group (lsmeans [95% CI]: 27.3% [23.3–
31.3] in ODF vs. 35.4% [32.2–38.5] in
CON and 32.4% [28.8–36.1] in OMED,
P  0.04). The FFM, adjusted for age and
sex, tended to be lower in ODF in com-
parison to CON and OMED, but did not
reach statistical signiﬁcance (57.9kg
[50.4–65.3] in ODF vs. 65.8 kg [60.0–
71.7] in CON, and 67.2 kg [60.4–74.1]
in OMED, P  0.1).
ODFs had lower fasting glucose, but
2-h plasma glucose concentrations were
comparablewiththoseofCONsorOMEDs
(P  0.01 and P  0.1, respectively,
ANOVA; Table 1). Despite similar fasting
plasma insulin concentrations and glucose
responsesduringtheOGTT,plasmainsulin
concentrations at 30 and 120 min during
OGTT (INS30, INS120) were lower in the
ODF group than in the CON and OMED
groups (F4.38, P0.02; F3.81, P
0.04, respectively; Fig. 1). After adjustment
for age, sex, 30 min glucose concentration,
and M-low, only INS30 remained lower in
the ODF group than in both the CON
and OMED groups (lsmeans [95% CI]:
722 pmol/l [132–1,582] in ODF vs.
2,699 pmol/l [2,047–3,352] in CON
and 1,790 pmol/l [1,367–2,206] in
OMED, P  0.01).
Intravenous glucose administration
resulted in a comparable increase in
plasma glucose levels in all three groups.
The insulin responses were signiﬁcantly
lower in ODF than in CON subjects (ef-
fect of diagnosis 
 time P  0.0001;
ANOVA; Fig. 1). In addition, log-
transformed AIR was lower in the ODF
groupthantheCONgroup(Table1),and
it remained signiﬁcant after adjustment for
age, sex, %BF, and M-low (lsmeans [95%
CI]: 2.08 pmol/l (1.96–2.20) in ODF vs.
2.55 pmol [2.24–2.75] in CON and 2.40
pmol/l [2.13–2.55] in OMED, P  0.05).
Duringthemealtest,therewasnodif-
ference in glucose responses between
groups. The insulin responses during the
meal test were signiﬁcantly lower in ODF
than in CON subjects (effect of diagno-
sis
time
sexP0.02;Fig.1).Plasma
insulin concentrations at 30 min of the
meal test were slightly lower in the ODF
group compared to both the CON and
OMED groups, but it did not reach statis-
tical signiﬁcance prior to adjustment
(1,084  462 pmol/l in ODF vs. 2090 
1,081 pmol/l in CON and 1,472  673
pmol/l in OMED, P  0.07; Fig. 1), or
followingadjustmentforage,sex,30-min
plasmaglucoseconcentration,andM-low
(lsmeans [95% CI]: 1,422 pmol/l [489–
2,355] in ODF vs. 2,087 pmol/l (1,372–
2,803)inCONand1,492pmol/l[1,059–
1924] in OMED, P  0.1).
ODFs were on average leaner (having
a lower %BF); therefore the mean log
transformed M-lows were higher in the
ODF group than in the CON and OMED
groups (Table 1), but after adjustment for
age, sex, and %BF, M-lows were compa-
rable in all three groups (lsmeans [95%
CI]: 2.68 [1.80–3.55] mg   kg
1   EMBS  
min
1 in ODF vs. 2.34 [1.73–2.96] mg  
kg
1 EMBS min
1inCON,2.28[1.87–
2.68]mg kg
1 EMBS min
1inOMED,
P  0.4). For all analyses, results did
not differ after accounting for family
membership.
CONCLUSIONS — Our analyses in-
dicate that adult nondiabetic offspring of
fathers with early onset of diabetes are
leaner than offspring of either mothers
with early onset of type 2 diabetes or con-
trol subjects (neither parent developed
type 2 diabetes by age 50 years). ODFs
had lower insulin secretion, demon-
strated by multiple tests (IVGTT, OGTT,
and meal test), but after adjusting for
body size, ODFs showed comparable in-
sulinactioninvivo.Previousstudieshave
shown that the offspring of individuals
with early-onset type 2 diabetes are at in-
creasedriskfordevelopingdiabetes(5,8).
Some studies report that the risk associ-
ated with maternal and paternal early on-
set of diabetes is approximately additive
(16), while others do not (17). The
presentanalysiswasundertakentoclarify
the separate effects of parental diabetes
on the offspring’s phenotype. To our
Table1—General,anthropometric,andbodycompositionparametersofsubjectsaccordingto
the age of diabetes onset in the parents
CON ODF OMED
n 15 10 11
Female/male (n) 6/9 2/8 6/5
Age (years) 28.4  8.2 22.9  6.1 26.4  6.9
Mother’s CI 0.440  0.495 0.577  0.347 0.851  0.047
Father’s CI 0.637  0.373 0.901  0.059 0.438  0.185
Birth weight (g)* 3,367  359 3,412  528 3,413  325
Body weight (kg) 104.5  30 79.6  19.6§ 98.4  12.2
Height (cm) 169  7 172  6 167  8
Body fat (%) 35.5  8.2 25.1  9.1§ 34.4  7.8
BMI (kg/m
2) 36.4  9.1 27.6  6.9§ 35.9  5.2
Fasting plasma glucose (mmol/l)† 5.19  0.40 4.55  0.55§ 5.22  0.43
2-h plasma glucose (mmol/l)† 6.58  1.28 5.88  1.33 7.33  1.55
NGT/IGT (n) 13/2 9/1 6/5
Log10M-low (mg   kgEMBS
1   min
1) 0.27  0.04 0.52  0.15§ 0.34  0.06
BGO (mg   kgEMBS   min
1) 2.33  0.33 2.62  0.09 2.43  0.48
Log10AIR (pmol/l)‡ 2.39  0.30 2.09  0.28§ 2.41  0.15
Data are means  SD. *Birth weight in ODF group available only in seven subjects. †In ODF group, data
available only in eight subjects. ‡NGT subjects only. §P  0.05 ODF vs. CON (ANOVA; sex differences 	
2
analysis). BGO, basal glucose output; IGT, impaired glucose tolerance; NGT, normal glucose tolerance.
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showapaternalinﬂuenceonadultbody
composition. While previous studies
have shown that offspring of diabetic fa-
thers have lower birth weights (3,18),
these studies did not explore parameters
for body composition at later ages.
Thegeneraleffectoffamilyhistoryon
offspring phenotype has been extensively
examined,butattemptstoseparatediffer-
ent parental effects have been more lim-
ited. Lindsay et al. (3) found that paternal
history of diabetes was associated with
lower birth weight. In fact, only those
withLBWandpaternalhistoryofdiabetes
hadincreaseddiabetesrisk,andLBWpre-
dicted diabetes risk in the father. Our re-
sults are in agreement with a previous
study also in Pima Indians (5) in which
lower AIR was associated with earlier on-
set of diabetes in either parent. In that
study, early onset was deﬁned as age of
onsetbelowthemedianageforthecohort
(age 41 years for mothers and 46
yearsforfathers).Inthosewhosemothers
developed diabetes at 35 years of age
(exclusiveofexposuretodiabetesinpreg-
nancy), insulin secretion rate was also
lower than in those whose parents devel-
oped type 2 diabetes at a later age.
However, it is not clear to what extent
differences in glucose tolerance (i.e.,
greater impaired glucose tolerance in
group of offspring of the mothers with
early onset of type 2 diabetes) may have
affected these results. Our results extend
andaddtotheseﬁndingsasweareableto
demonstrate in different tests (IVGTT,
OGTT, and meal tests) done on different
days a consistently lower AIR. During the
OGTT, the 30-min insulin remained
lower in ODF compared to both OMED
and CON, even after adjustment for age,
sex, 30-min glucose, and M-low. In con-
trast, the 120-min insulin was no longer
signiﬁcantly lower after the same adjust-
ments. These results indicate that the pri-
maryeffectofearlypaternaldiabetesison
earlyinsulinsecretion,ratherthaninsulin
action. This is supported by the relatively
lowerfastingplasmaglucoseinODFsand
the lack of a difference in M-low after ad-
justment for body size.
Our results imply an imprinted effect
identiﬁed by early-onset paternal diabe-
tes. Imprinting is the expression of only a
single copy of a gene depending on par-
ent-of-origin and is commonly found in
genes that affect fetal growth. There are at
least two distinct mechanisms through
which epigenetic information can be in-
herited:DNAmethylation(commonlyas-
sociated with gene silencing and a
contributor to X chromosomal inactiva-
tion) and histone modiﬁcation (19). Nu-
merous genes have been found to be
imprinted, and some of them are also in-
volved in longitudinal and skeletal
growthandmayalsobeinvolvedinorgan
growth (20). Notable among them are
genes such as IGF-2, a growth hormone
signaling gene (21). In the human liver,
the major production source of circulat-
ing IGF-2, the IGF-2 gene is maternally
imprinted during fetal life, whereas post-
natally IGF-2 is primarily transcribed
from the P1 promoter, which is bialleli-
cally active in the liver. In other adult tis-
sue (including the pancreas), IGF-2 is
mainlytranscribedfromthepaternallyac-
tive promoters (22). Animal studies have
demonstratedthatgenesinvolveddirectly
in pancreatic -cell development might
be imprinted, e.g., the gene for insulin
Figure 1—Plasma glucose and insulin concentrations during OGTT (A and B), during IVGTT (C and D), and during meal test (E and F)i nO D F
F, CON  , and OMED Œ. Statistical signiﬁcance as revealed by two-way ANOVA for the time and group factors and their interactions (time 

group). OGTT: Post hoc tests for signiﬁcant differences in time versus group interactions (effect of time [P  0.0001 for all models]); effect of group
(glucose P  0.02, insulin P  0.001); effect of time 
 groups interaction (glucose P  0.3, insulin P  0.1). IVGTT: Post hoc tests for signiﬁcant
differencesintimeversusgroupinteractions(effectoftime[P0.0001forallmodels]);effectofgroup(glucoseP0.02,insulinP0.0001);effect
oftime
groupsinteraction,(glucoseP0.3,insulinP0.0001).IVGTTdataavailableonlyinsixsubjectsintheODF,sixintheCON,andseven
intheOMEDgroup.Mealtest:Posthoctestsforsigniﬁcantdifferencesintimeversusgroupinteractions(effectoftime[P0.0001forallmodels]);
effectofgroup(glucoseP0.2,insulinP0.0001);effectoftime
groupsinteraction(glucoseP0.3,insulinP0.002).Mealtestdataavailable
only in six subjects in the ODF, eight in the CON, and eleven in the OMED group. Data are expressed as means  SE. *P  0.05 for speciﬁc time
intervals.
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studydemonstratesthatgenesessentialto
pancreatic development, such as pancre-
atic homeobox transcription factor-1
(Pdx-1)aresusceptibletoepigeneticmod-
iﬁcations (23). In humans, an indepen-
dent association between paternal insulin
resistance and cord insulin concentra-
tions (24) also indicates indirect evidence
of imprinting.
Genes related to adipocyte develop-
ment, speciﬁcally preadipocyte factor 1
(Pref1), Necdin, and paternally expressed
gene 1 (Peg1) can be imprinted (6). Pref1
(aninhibitorofadipogenesis)isexpressed
from the paternally inherited chromo-
some, and imprinting of Pref1 is under
complex control by both maternal and
paternal alleles (6). Although a study in
mice overexpressing Pref1 showed re-
duced fat content (25), additional studies
arerequiredtoelucidatethepotentialrole
of epigenetic effects in adipose tissue de-
velopment in humans.
Because of our stringent group crite-
ria,oursamplesizeissmall.However,our
ﬁndingsofaleanerphenotypeintheODF
group are robust and consistent with the
previous ﬁndings of LBW in this group.
Our results could have been affected by
the fact that these individuals were stud-
ied in adulthood, and so any individuals
who developed type 2 diabetes prior to
age 18 years were excluded. However,
this would have, if anything, reduced our
power to see group differences, particu-
larly in an important diabetes risk factor
such as AIR. Although the age of onset of
diabetes in the parents was quite young,
there was a slight (3.8  4.0 years) but
statistically signiﬁcant difference in the
age of onset of diabetes in parents of the
ODF versus OMED group. However,
the AIR in ODF was markedly lower
across different tests on different days,
implyingthatthepaternaleffectwasmore
importantthanthisrelativelysmalldiffer-
ence in age of diagnosis.
In conclusion, the results of the
present analyses indicate that offspring of
fathers with early-onset diabetes are
leaner and have lower early insulin secre-
tion compared to individuals in whom
both parents remained without diabetes
up to 50 years of age. Insulin action, after
adjustmentforbodysize,wascomparable
in all three groups of offspring. These
ﬁndings indicate an important role of pa-
ternal heritability in body composition
and -cell dysfunction. Paternal trans-
mission patterns for susceptibility to
diabetes indicate that epigenetic mecha-
nisms are involved in the predisposition
to diabetes. Whether epigenetic markers
are associated with parent-of-origin ef-
fects needs further investigation.
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